Corpus Intelligence IC Memo — LEXINGTON MEMORIAL HOSPITAL INC. 2026-04-26 14:14 UTC
IC Memo — LEXINGTON MEMORIAL HOSPITAL INC.
Investment Committee Memorandum | NC | 70 beds | Grade C | EBITDA uplift $10.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

LEXINGTON MEMORIAL HOSPITAL INC.

CCN 340096 | DAVIDSON, NC | 70 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

LEXINGTON MEMORIAL HOSPITAL INC. is a 70-bed suburban community hospital in DAVIDSON, NC with $138.3M in net patient revenue and a 6.9% operating margin. The hospital serves a payer mix of 19.6% Medicare, 6.6% Medicaid, and 73.7% commercial.

Thesis: Turnaround. Our ML models identify $10.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 6.9% to 14.2% (+736bps).

Net Revenue HCRIS$138.3M
Current EBITDA COMPUTED$9.5M
Operating Margin COMPUTED6.9%
Occupancy HCRIS57.2%
Revenue / Bed COMPUTED$2.0M
Net-to-Gross HCRIS29.5%
Distress Probability ML45.5%

2. Market Context & Competitive Position

129
NC Hospitals
-2.0%
State Median Margin
51
Comparable Hospitals

NC has 129 Medicare-certified hospitals with a median operating margin of -2.0%. The target's margin of 6.9% places it above the state median. Among 51 size-comparable peers (35-140 beds), the median margin is -2.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (35-140), prioritizing same-state peers. 51 hospitals in the comp set.

HospitalStateBedsRevenueMargin
LEXINGTON MEMORIAL HOSPITAL I (Target)NC70$138.3M6.9%
ATRIUM HEALTH UNIVERSITY CITYNC104$286.9M28.6%
PRESBYTERIAN HOSPITAL HUNTERSVNC135$276.7M21.8%
ADVENTHEALTH HENDERSONVILLENC73$227.1M-4.1%
THOMASVILLE MEDICAL CENTERNC73$220.3M-14.3%
SCOTLAND MEMORIAL HOSPITALNC104$198.0M-2.8%
WATAUGA MEDICAL CENTERNC95$187.3M2.4%
CARTERET COUNTY GENERAL HOSPITNC99$187.2M6.4%
CALDWELL MEMORIAL HOSPITALNC137$166.2M-1.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $10.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.9M+210bp18mo
Cost to Collect4.5%2.5%$2.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.7M+122bp9mo
Clean Claim Rate88.0%96.0%$89K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.9M
Cost to Collect
$2.8M
Denial Rate Reduction
$2.7M
A/R Days Reduction
$1.7M
Clean Claim Rate
$89K
Total EBITDA Uplift$10.2M
Current EBITDA$9.5M
+ RCM Uplift+$10.2M
Pro Forma EBITDA$19.7M
Current Margin6.9%
Pro Forma Margin14.2%
WC Released (1x)$5.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$14.6M$164.3M11.27x62.3%
Base (11x exit)10.0x11.0x$14.6M$185.5M12.72x66.3%
Bull Case9.0x11.0x$13.1M$223.9M17.05x76.3%
Bull (12x exit)9.0x12.0x$13.1M$248.1M18.89x80.0%
Bear Case11.0x10.0x$16.0M$108.7M6.77x46.6%
Bear (11x exit)11.0x11.0x$16.0M$124.8M7.78x50.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 51 hospitals with 35-140 beds
  • Same-state prioritization (n=52)
  • Comp margins: P25=-10.3% / P50=-2.0% / P75=12.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.